Study reveals privacy risks in female health apps

FHS
May 15, 2024
12:08 pm

Apps designed for female health monitoring are exposing users to unnecessary privacy and safety risks through their poor data handling practices, according to new research from UCL and King’s College London.

ARCH, Medicines Co. veterans raise $290 million for in-licensed obesity drugs

After scouring 200 companies’ pipelines — including a few overlooked pharma shelves — a new company backed by investment firm Population Health Partners and ARCH

April 18, 2024

Shareholders approve all proposals – Biotech Investments

Galenica AG / Key word(s): AGMEGM 7th Annual General Meeting: Shareholders approve all proposals 10.04.2024 / 17:29 CET/CEST Press release The seventh Annual General Meeting

April 11, 2024

Arbutus reduces headcount after axing HBV combo trial that features Imfinzi

Arbutus plans to lay off 40% of its staff after ending one of three ongoing midstage hepatitis B trials. The decision to cut the study

August 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.